SANDRA CORNINE: Open Payments
NPI 1538813324 · OKEECHOBEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$436 in 20 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $526 · 2025 $436
Food & beverage: $436
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 6 | $149 |
| Corcept Therapeutics | 3 | $50 |
| ABBVIE INC. | 2 | $48 |
| Novo Nordisk Inc | 2 | $42 |
| Lilly USA, LLC | 1 | $30 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| PFIZER INC. | 1 | $19 |
Products named: Qelbree, Korlym, VRAYLAR, ZEPBOUND, TZIELD, Ozempic, CAPVAXIVE, Auvelity.
Industry payments across FL — which companies pay providers there.
